Mr. Speaker, the member is on the health committee as well and knows or should know that when a shortage arises, Health Canada, consistent with its mandate and authority, works closely with purchasers and suppliers to ensure that any new supplies of needed drugs are safe, effective and high quality. That is the federal jurisdiction.
Health Canada has a variety of tools available to help do this. It works closely with companies so they can quickly resolve manufacturing quality and distribution issues, which is happening right now, and works with manufacturers to ensure alternative suppliers. Changes in the manufacturing process or location can be reviewed and the market is authorized on a priority basis. These are all things to help the drug shortage situation.